Marek Jan Atter

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 11, 2026
Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling.

|May 09, 2026
Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluation.

|Feb 24, 2026
Intravenous lidocaine for gastrointestinal recovery after colorectal surgery: the ALLEGRO placebo-controlled randomised trial and cost-effectiveness analysis.

Hugh Paterson, Thenmalar Vadiveloo, Karen Innes

|Nov 05, 2025
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial.

Marek Jan Atter, Peter Hall, Rachael A Evans

|Feb 25, 2025
Intravenous lidocaine for gut function recovery in colonic surgery: a health economic evaluation of the ALLEGRO randomised clinical trial.

Marek Atter, Andrew Stoddart, Seonaidh Cotton

Pageof 1

Frequent Collaborators

3 joint publications

John Norrie

2 joint publications

Karen Innes

2 joint publications

Zoe Batham

2 joint publications

Graeme MacLennan